Yi‐Ping Hung

1.3k total citations
45 papers, 839 citations indexed

About

Yi‐Ping Hung is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yi‐Ping Hung has authored 45 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Epidemiology. Recurrent topics in Yi‐Ping Hung's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Gastric Cancer Management and Outcomes (6 papers). Yi‐Ping Hung is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Gastric Cancer Management and Outcomes (6 papers). Yi‐Ping Hung collaborates with scholars based in Taiwan, United States and South Korea. Yi‐Ping Hung's co-authors include Yee Chao, Chung‐Pin Li, Jack Wang, Chen‐Yi Wu, Shinn‐Jang Hwang, I-Hsuan Hwang, Tzeng‐Ji Chen, Ming‐Huang Chen, San‐Chi Chen and Chiu‐Mei Yeh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yi‐Ping Hung

42 papers receiving 831 citations

Peers

Countries citing papers authored by Yi‐Ping Hung

Since Specialization

Citations

This map shows the geographic impact of Yi‐Ping Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Ping Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Ping Hung more than expected).

Fields of papers citing papers by Yi‐Ping Hung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Ping Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Ping Hung. The network helps show where Yi‐Ping Hung may publish in the future.

Co-authorship network of co-authors of Yi‐Ping Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Ping Hung. A scholar is included among the top collaborators of Yi‐Ping Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Ping Hung. Yi‐Ping Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma 2025 ·BMC Cancer ·San‐Chi Chen, (unknown), Chien-An Liu, Yi‐Ping Hung, Nai‐Jung Chiang, (unknown), Yee Chao, (unknown)	3
2	Characteristics and prognosis of skip lymph node metastasis in gastric cancer: a retrospective study 2025 ·World Journal of Surgical Oncology ·Kwok Wai Lo, Kuo‐Hung Huang, Wen-Liang Fang, Shih‐Chieh Lin, Yi‐Ping Hung, Ming‐Huang Chen, (unknown), (unknown)	0
3	Unharvested palm fruit bunch ripeness detection with hybrid color correction 2024 ·SHILAP Revista de lepidopterología ·(unknown), Rajendran Parthiban, Vineetha Kalavally, Yi‐Ping Hung, Xin Wang	1
4	Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non‐Liver Malignancies in Hepatitis B Endemic Areas 2024 ·Alimentary Pharmacology & Therapeutics ·Yi‐Ping Hung, Pei‐Chang Lee, Yen‐Hwa Chang, Muh‐Hwa Yang, Chao‐Hua Chiu, Ming‐Huang Chen, Keng‐Hsin Lan, I‐Cheng Lee, Ming‐Chih Hou, Yee Chao, Yi‐Hsiang Huang	3
5	Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model 2024 ·BMC Cancer ·Yi‐Ping Hung, (unknown), Jiun‐I Lai, Muh‐Hwa Yang, (unknown), Yee Chao	0
6	Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study 2022 ·Clinical Cancer Research ·(unknown), Kien Thiam Tan, Li‐Yuan Bai, Chin‐Fu Hsiao, Chung‐Yu Huang, Yi‐Ping Hung, (unknown), San‐Chi Chen, Yan‐Shen Shan, Yee Chao, Yi‐Hsiang Huang, I‐Cheng Lee, Pei‐Chang Lee, Yung‐Yeh Su, Shu‐Jen Chen, Chun‐Nan Yeh, Li‐Tzong Chen, Ming‐Huang Chen	13
7	A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer 2022 ·Neoplasia ·(unknown), Yu‐Chan Chang, (unknown), Ya-Chi Hung, (unknown), Yi‐Ping Hung, Nai‐Jung Chiang, Chun‐Nan Yeh, Michael Hsiao, John Soong, Yeu Su, Ming‐Huang Chen	11
8	Microsatellite Instability, Epstein–Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer 2022 ·Cancers ·(unknown), Chung‐Pin Li, Yi‐Hsiang Huang, Shao‐Jung Hsu, Yen‐Po Wang, Yun‐Cheng Hsieh, Wen‐Liang Fang, Kuo‐Hung Huang, Anna Fen‐Yau Li, Rheun‐Chuan Lee, (unknown), Yuan‐Hung Wu, I‐Chun Lai, (unknown), Yi‐Ping Hung, Yu‐Chao Wang, Shuhui Chen, Ming‐Huang Chen, Yee Chao	15
9	Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment 2022 ·Viruses ·I‐Cheng Lee, Pei‐Chang Lee, Yee Chao, (unknown), (unknown), Yi‐Ping Hung, Chien‐Wei Su, Ming‐Chih Hou, Yi‐Hsiang Huang	5
10	Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience 2022 ·Investigational New Drugs ·Wen‐Chi Wu, (unknown), (unknown), Yi‐Ping Hung, Chien‐An Liu, Rheun‐Chuan Lee, Yi‐Hsiang Huang, Yee Chao, San‐Chi Chen	32
11	Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study 2022 ·BMC Cancer ·San‐Chi Chen, Yi‐Hsiang Huang, Ming‐Huang Chen, Yi‐Ping Hung, Rheun‐Chuan Lee, Yu‐Yun Shao, Yee Chao	20
12	A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy 2020 ·The Oncologist ·Zhong‐Zhe Lin, Bang‐Bin Chen, Yi‐Ping Hung, (unknown), Ying‐Chun Shen, Yu‐Yun Shao, Chih‐Hung Hsu, Ann‐Lii Cheng, Rheun‐Chuan Lee, Yee Chao, Chiun Hsu	17
13	Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center 2017 ·Journal of the Chinese Medical Association ·(unknown), (unknown), Ming‐Huang Chen, (unknown), Chung‐Pin Li, Yi‐Ping Hung, Cheng‐Yuan Hsia, (unknown), Gar‐Yang Chau, Yee Chao	20
14	Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study 2016 ·PLoS ONE ·Man‐Hsin Hung, Chia-Jen Liu, Chung‐Jen Teng, Yu‐Wen Hu, Chiu‐Mei Yeh, San‐Chi Chen, Sheng‐Hsuan Chien, Yi‐Ping Hung, Cheng‐Che Shen, Tzeng‐Ji Chen, Cheng‐Hwai Tzeng, Chun‐Yu Liu	24
15	Secondary Primary Malignancy Risk in Patients With Ovarian Cancer in Taiwan 2015 ·Medicine ·Yi‐Ping Hung, Chia-Jen Liu, Yu‐Wen Hu, (unknown), (unknown), Chiu‐Mei Yeh, Tzeon‐Jye Chiou, Tzeng‐Ji Chen, (unknown), Yee Chao	17
16	Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan 2015 ·Medicine ·Chung‐Jen Teng, Leh‐Kiong Huon, Yu‐Wen Hu, Chiu‐Mei Yeh, Yee Chao, Muh‐Hwa Yang, Tzeng‐Ji Chen, Yi‐Ping Hung, Chia‐Jen Liu	26
17	Risk of Ischemic Stroke in Patients With Gastric Cancer 2015 ·Medicine ·(unknown), San‐Chi Chen, Chiu‐Mei Yeh, Man‐Hsin Hung, Yi‐Ping Hung, Tzeng‐Ji Chen, Chia-Jen Liu	16
18	Incidence and risk of mood disorders in patients with breast cancers in Taiwan: a nationwide population‐based study 2013 ·Psycho-Oncology ·Yi‐Ping Hung, Chia‐Jen Liu, Chia‐Fen Tsai, Man‐Hsin Hung, Cheng‐Hwai Tzeng, Chun‐Yu Liu, Tzeng‐Ji Chen	36
19	Easy and Deep Media in Cultural Heritage Field —The Development of Mau-kung Ting Educational Media for the National Palace Museum 2013 ·International Journal of Education and Management Engineering ·(unknown), (unknown), (unknown), Chung‐Yi Chang, (unknown), Yi‐Ping Hung	1
20	Error Analysis on Closed-Form Solutions for Kinematic Calibration 1996 ·Sheng-Wen Shih, Yi‐Ping Hung, Wenwei Lin	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact